Month: <span>March 2016</span>

FDA’s reporting requirements are relaxed with respect to active ingredient producer for drugs; trade names for biologics, drugs, tobacco, radiation products; intended use reporting for certain products; and device listing…

Product Regulation U.S. Federal Agencies